Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Iambic Therapeutics, Inc
Beijing Biotech
Amgen
National Institutes of Health Clinical Center (CC)
Neonc Technologies, Inc.
Essen Biotech
Var2 Pharmaceuticals
Novartis
Mayo Clinic
Cancer Research UK
Merck Sharp & Dohme LLC
LigaChem Biosciences, Inc.
Washington University School of Medicine
Jonsson Comprehensive Cancer Center
Telix Pharmaceuticals (Innovations) Pty Limited
PharmaMar
Apollomics Inc.
Columbia University
Stanford University
Universidade Federal de Pernambuco
Aminex Therapeutics, Inc.
Washington University School of Medicine
NGM Biopharmaceuticals, Inc
University of Florida
Quadriga Biosciences, Inc.
Hospices Civils de Lyon
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Shenzhen BinDeBio Ltd.
Novartis
Southwest Hospital, China
Shenzhen BinDeBio Ltd.
Icahn School of Medicine at Mount Sinai
Stanford University
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
University of Arizona
National Cancer Institute (NCI)
SWOG Cancer Research Network
University of California, San Francisco
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)